• Fri. Oct 22nd, 2021

Covid vaccines and thrombosis, the first study in Milan: volunteers wanted

Byeditorial

May 20, 2021

“The first clinical study in Italy that investigates the connection between anti-Covid vaccination and thrombotic events” starts in Milan. It was led by the Monzino Cardiology Center (Ccm) and the State University of the Lombard capital, who announce the launch of the ‘Treasure’ project with the aim of “evaluating any variation in platelet activation, the mechanism at the origin thrombosis, induced by the administration of both mRna vaccines such as Pfizer and Moderna, and viral vector vaccines such as AstraZeneca and Johnson & Johnson “. Monzino and UniMi are looking for 200 Milanese interested in participating in the research, undergoing a simple blood test before and after vaccination. “Participate in the study” is the appeal launched by the IRCCS of the heart and by the university in via Festa del Perdono. “In addition to contributing to the collective knowledge on anti-Covid vaccines – they underline – the participants will enter a program to control their cardiovascular situation, which it is always good to monitor, especially in this pandemic period”. characterize the state of platelet activation before vaccination and evaluate any post-vaccine variation, also highlighting whether different types of shield product determine a different platelet activation. Treasure is aimed at the population aged 18 to 79, who must receive the first or second dose of Sars-Cov-2 vaccine. “The cases of thrombosis, although rare, following the administration of the AstraZeneca vaccine, have sown panic. But in reality there is no scientific proof of a causal link, nor that women are more at risk – says Marina Camera, professor at the University of Milan and head of the Cardiovascular Cell and Molecular Biology Unit of the CCM – For this reason, international scientific societies have recommended investigating the mechanisms of interaction between blood cells and vaccines. An invitation that we immediately accepted. The anti-Covid vaccination campaign will not end in 2021, but will accompany us for several years as central theme of public health “, underlines the expert, highlighting the importance of the experiment.” According to the recommendations issued by the European health authorities after a first examination and of the available data – Camera remembers – the most suspected are viral vector vaccines, so much so that in Italy they are reserved “preferentially” for over 60s, an age in which thrombotic events did not occur. The doubt remains that the reported cases, very few, compared to the millions of doses already administered in England and in the United States – points out the teacher – have nothing to do with the vaccine. Data in hand, in fact, their number is practically identical to the thrombosis affecting the unvaccinated population. For this, it is absolutely necessary to know more “. And it is essential” not to suspend or slow down the vaccination campaign: getting sick with Covid-19 – warns Camera – is much more dangerous than getting a vaccine. I therefore appeal to the Milanese to participate in our study and help research “.

One thought on “Covid vaccines and thrombosis, the first study in Milan: volunteers wanted”
  1. editorial says:

    https://connect.informs.org/network/members/profile?UserKey=61cee7f5-ceb6-4b9f-83f7-e55b33df1406
    https://connect.informs.org/network/members/profile?UserKey=64220829-70bf-4641-873a-4d84f4e81f89
    https://connect.informs.org/network/members/profile?UserKey=918c86f1-206e-4e84-ab30-eb51c18d74aa
    https://connect.informs.org/network/members/profile?UserKey=d3e11175-f216-475e-b728-ed4e41dbb5a6
    https://connect.informs.org/network/members/profile?UserKey=e05681ab-2fb1-449e-811e-2571e7e6785a
    https://connect.informs.org/network/members/profile?UserKey=46f43f14-4a0a-4fec-bf33-6623e9fb53c1
    https://connect.informs.org/network/members/profile?UserKey=4687bb49-ecc1-4ab5-9eb4-2c1b5d6410ef
    https://connect.informs.org/network/members/profile?UserKey=02aca666-1aed-422a-ad58-92a56a87fec6
    https://connect.informs.org/network/members/profile?UserKey=22334e6f-bf3a-442f-b1c7-c86ffa340e6e
    https://connect.informs.org/network/members/profile?UserKey=53927e20-833d-495d-a946-38ba2ad60bb7
    https://connect.informs.org/network/members/profile?UserKey=fa92a8df-a014-4229-ae87-0108d77b1d95
    https://connect.informs.org/network/members/profile?UserKey=81e6ec98-ff06-45db-a327-2dd6af0adba2
    https://connect.informs.org/network/members/profile?UserKey=62e71217-0b97-4503-bfd5-b052f4bbbff4
    https://connect.informs.org/network/members/profile?UserKey=bd3977ee-ab4a-4c9a-8e8a-8c0eb9dd85c5
    https://connect.informs.org/network/members/profile?UserKey=f68470e9-07c1-4709-9f09-515e41496d81
    https://connect.informs.org/network/members/profile?UserKey=5128d00e-b5bb-433e-bcbd-50a82afd77d3
    https://connect.informs.org/network/members/profile?UserKey=515660ae-8581-46f8-8207-3d56902f144d
    https://connect.informs.org/network/members/profile?UserKey=f667189e-4a6b-48c0-a968-700250165eb9
    https://connect.informs.org/network/members/profile?UserKey=c7f44216-078c-4a21-a42f-13a4a2d1fe17
    https://connect.informs.org/network/members/profile?UserKey=1d9a1b08-6390-4546-885a-e8c2f5ce0692
    https://connect.informs.org/network/members/profile?UserKey=f6deff43-516c-41a9-b337-3bb6d886c302
    https://connect.informs.org/network/members/profile?UserKey=95881e57-7d79-4fc5-9a34-eedce4583fd9
    https://connect.informs.org/network/members/profile?UserKey=2329288d-e00e-450f-bf37-438a1137ed38
    https://connect.informs.org/network/members/profile?UserKey=feb9fb4c-7d92-4b12-8357-0e4dc663f885
    https://connect.informs.org/network/members/profile?UserKey=a3791cfb-d2cc-498f-83c1-c194c946dc1e
    https://connect.informs.org/network/members/profile?UserKey=931f5ca7-af09-4f1f-85a0-c9bf65b112b8
    https://connect.informs.org/network/members/profile?UserKey=f1d8f378-2840-4004-91ed-58a54cb76dcf
    https://connect.informs.org/network/members/profile?UserKey=96961728-280c-493c-acb3-569f2b863a28
    https://connect.informs.org/network/members/profile?UserKey=5a370104-16cb-485c-8454-6fde425acc6b
    https://connect.informs.org/network/members/profile?UserKey=59c67d91-4270-49e9-8994-fffb52b4abbe
    https://connect.informs.org/network/members/profile?UserKey=3bbf3c1b-0706-4bd1-a750-e05390d9227d
    https://connect.informs.org/network/members/profile?UserKey=c9a67f4d-e01f-4b2f-b30d-8870d930ea85
    https://connect.informs.org/network/members/profile?UserKey=3751a370-cf50-4ffe-89db-546d6308561b
    https://connect.informs.org/network/members/profile?UserKey=26dbd8bb-946d-4899-a813-46e9ce8b9d80
    https://connect.informs.org/network/members/profile?UserKey=0e5bb4da-177b-4370-a749-06e25c235a96
    https://connect.informs.org/network/members/profile?UserKey=a4d20b3d-f450-4b69-b8a6-84047c525af1
    https://connect.informs.org/network/members/profile?UserKey=180033fb-affa-499e-aeba-0700c899345d
    https://connect.informs.org/network/members/profile?UserKey=4437f4c1-4f9c-4d7a-abb7-c02f02c8ca74
    https://connect.informs.org/network/members/profile?UserKey=c6071899-d985-464f-80d2-ff67e6aeb115
    https://connect.informs.org/network/members/profile?UserKey=c0e16c97-c2ee-45a6-99b7-db01e39154a0
    https://connect.informs.org/network/members/profile?UserKey=efbbb991-22e6-4a0e-bfd6-0c386264b22b
    https://connect.informs.org/network/members/profile?UserKey=b9638fd2-eb6f-4617-a475-82bf58f20217
    https://connect.informs.org/network/members/profile?UserKey=040242fd-267d-41f7-8635-6b8715722743
    https://connect.informs.org/network/members/profile?UserKey=df869c17-9a54-49b2-8381-1fa60af46b51
    https://connect.informs.org/network/members/profile?UserKey=6bc2850a-9913-4bf5-9bca-08be065381a6
    https://connect.informs.org/network/members/profile?UserKey=5c33ce14-1c7e-419e-8e38-f02437b588ac
    https://connect.informs.org/network/members/profile?UserKey=639a19f8-962c-4f19-8041-a74de67f6a7c
    https://connect.informs.org/network/members/profile?UserKey=b46201b9-4f19-4fcd-b510-b0126338c2ce
    https://connect.informs.org/network/members/profile?UserKey=f6076dfd-6302-4dbf-9ca9-fa423fc80eda
    https://connect.informs.org/network/members/profile?UserKey=2d9e6c1a-7af5-47e0-b2df-bbd0660259a2

Comments are closed.